HSDT

SEC source: 0001209191-18-031242 · doc4.xml · derivative · entry 1

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031241 · doc4.xml · derivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031240 · doc4.xml · derivative · entry 1

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031239 · doc4.xml · derivative · entry 2

Tyler Mitch E · CIK 0001638208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Class A Common Stock · 12,500 shares

Expires 2028-05-15

F2 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F3 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031238 · doc4.xml · derivative · entry 1

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Class A Common Stock · 80,000 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031237 · doc4.xml · derivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Class A Common Stock · 95,000 shares

Expires 2028-05-15

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-031236 · doc4.xml · derivative · entry 2

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Class A Common Stock · 80,000 shares

Expires 2028-05-15

F3 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F4 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001209191-18-025249 · doc4.xml · derivative · entry 2

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,346

Underlying: Class A Common Stock · 3,346 shares

Expires 2021-04-10

F2 · derivative.exercise_price: The strike price of the Warrant is CAD$12.25.

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $7.47.

F3 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-18-025249 · doc4.xml · nonDerivative · entry 1

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,346

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $7.47.

SEC source: 0001209191-18-031236 · doc4.xml · nonDerivative · entry 1

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,403

F1 · kind: Pro rata distribution from Clinvue LLC, of which the Reporting Person was a member.

F2 · balance_after: The amount reported reflects a pro rata distribution to members of MPJ Healthcare. In prior reports, the Reporting Person reported beneficial ownership of 641,401 shares, on a post-split basis.

SEC source: 0001209191-18-031239 · doc4.xml · nonDerivative · entry 1

Tyler Mitch E · CIK 0001638208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 829,545

F1 · kind: Pro rata distribution from Advanced NeuroRehabilitation, LLC, of which the Reporting Person was a member.

SEC source: 0001209191-17-067263 · doc4.xml · derivative · entry 2

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,653

Underlying: Class A Common Stock · 382,653 shares

Expires 2020-12-22

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-17-067263 · doc4.xml · nonDerivative · entry 1

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 422,653

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

SEC source: 0001209191-17-067261 · doc4.xml · derivative · entry 2

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,082

Underlying: Class A Common Stock · 79,082 shares

Expires 2020-12-22

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001209191-17-067261 · doc4.xml · nonDerivative · entry 1

LaViscount Joyce N · CIK 0001372528 · CFO and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,306

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

SEC source: 0001209191-17-067260 · doc4.xml · derivative · entry 3

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By LLC

Disclosed balance after: 127,551

Underlying: Class A Common Stock · 127,551 shares

Expires 2020-12-22

F2 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F4 · derivative.exercise_date: Immediately exercisable.

F1 · ownership.nature: These securities were purchased by Deschamps Global Healthcare Commercialization LLC (the "LLC"). The Reporting Person is the sole member of the LLC.

SEC source: 0001209191-17-067260 · doc4.xml · nonDerivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By LLC

Disclosed balance after: 3,334,556

F1 · shares: These securities were purchased by Deschamps Global Healthcare Commercialization LLC (the "LLC"). The Reporting Person is the sole member of the LLC.

F2 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F3 · ownership.nature: Represents shares directly held by the LLC and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC.

SEC source: 0001209191-17-067259 · doc4.xml · derivative · entry 6

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 83,147

Underlying: Class A Common Stock · 83,147 shares

Expires 2020-12-22

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F5 · derivative.exercise_date: Immediately exercisable.

F4 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-067259 · doc4.xml · derivative · entry 5

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 30,927

Underlying: Class A Common Stock · 30,927 shares

Expires 2020-12-22

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F5 · derivative.exercise_date: Immediately exercisable.

F3 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-067259 · doc4.xml · derivative · entry 4

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 141,027

Underlying: Class A Common Stock · 141,027 shares

Expires 2020-12-22

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F5 · derivative.exercise_date: Immediately exercisable.

F2 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-067259 · doc4.xml · nonDerivative · entry 3

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 789,435

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F4 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-067259 · doc4.xml · nonDerivative · entry 2

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 325,338

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F3 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-067259 · doc4.xml · nonDerivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,485,796

F1 · price: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F2 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-061848 · doc4.xml · nonDerivative · entry 2

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40- $2.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001209191-17-061848 · doc4.xml · nonDerivative · entry 1

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.35 - $2.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 9

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 706,288

F3 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 8

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 294,411

F2 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 7

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,344,769

F1 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 6

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 698,117

F3 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 5

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 291,372

F2 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 4

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,330,979

F1 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 3

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 671,317

F3 · ownership.nature: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 2

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 281,405

F2 · ownership.nature: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-060268 · doc4.xml · nonDerivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,285,746

F1 · ownership.nature: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-17-048639 · doc4.xml · derivative · entry 1

ANDREEFF DANE · CIK 0001201810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2027-08-08

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.26675 on August 8, 2017; based on exercise price of CAD $2.63.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest over four years, with 25% of the shares vesting on August 8, 2018 and the remaining shares vesting annually in three equal installments on August 8, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010590 · doc4.xml · derivative · entry 1

STRAW EDWARD M · CIK 0001075380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010595 · doc4.xml · derivative · entry 1

Walter Blane · CIK 0001340555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010593 · doc4.xml · derivative · entry 1

Tyler Mitch E · CIK 0001638208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Class A Common Stock · 85,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010591 · doc4.xml · derivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Class A Common Stock · 1,000,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010592 · doc4.xml · derivative · entry 1

Peng Huaizheng · CIK 0001662081 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010588 · doc4.xml · derivative · entry 1

GRIFFIN THOMAS E · CIK 0001625114 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010514 · doc4.xml · derivative · entry 1

LaViscount Joyce N · CIK 0001372528 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Class A Common Stock · 800,000 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010583 · doc4.xml · derivative · entry 2

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,624

Underlying: Class A Common Stock · 326,624 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F3 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0000899243-17-010583 · doc4.xml · derivative · entry 1

Sackier Jonathan · CIK 0001638293 · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 473,376

Underlying: Class A Common Stock · 473,376 shares

Expires 2027-04-17

F1 · derivative.exercise_price: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.0000 = CAD $1.3277 on April 17, 2017; based on exercise price of CAD $2.16

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Stock Incentive Plan. The shares vest over four years with 25% of the shares vesting on April 17, 2018 and the remaining shares vesting annually in three equal installments on April 17, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each applicable vesting date.